Penn Medicine Provider
Psychiatry
Robert Weinrieb, MD
he/him/his
Accepting new patients
Sees patients age 18 and up
Penn Transplant Institute - Liver Transplant
Make an appointmentCall 800-789-7366

About me

  • Chief Psychiatric Consultant, Penn Transplant Institute
  • Program Director, Consultation-Liaison Psychiatry Fellowship
  • Professor of Psychiatry at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: State University of New York at Buffalo
  • Residency: Saint Vincent's Medical Center
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Weinrieb is a Penn Medicine physician.

Qualifications and experience

My research

Nguyen L, Forte A, Malat G, Liu X, Rivera J, Christopher C, Samudralwar R, Ilori T, Bleicher M, Redfield RR III, Weinrieb R, Bloom RD, Dunn TB, Trofe-Clark J Program Evaluation of Pharmacist-Performed Medication Adherence Assessments in Candidates for Living Donor Kidney Transplant , Progress in Transplantation, 34(3): 2024,141-147

Goswami-Banerjee A, Weinberg E, Coraluzzi L, Bitterman T, Nahas J, Addis S, Weinrieb R, Serper M A tailored virtual program for alcohol use disorder treatment among liver transplant candidates and recipients is feasible and associated with lower post-transplant relapse , Clinical Transplantation, 38 (7): 2024

Weinrieb Robert, Medda Rituparna, Lucey Michael, R Therapy of alcohol use disorder in liver transplant recipients , Liver Transplantation: 2024

Robert M. Weinrieb, Michael A. Strong Psychiatric Evaluation of the Liver Transplant Candidate with Alcohol Associated Hepatitis , Transplant Psychiatry: A Case-Based Approach to Clinical Challenges : 2023,145-152

Deutsch-Link S, Bittermann T, Nephew L, Ross-Driscoll K, Weinberg EM, Weinrieb RM, Olthoff KM, Addis S, Serper M. Racial and Ethnic Disparities in Psychosocial Evaluation and Liver Transplant Waitlisting , American Journal of Transplantation: 2023,https://doi.org/10.1016/j.ajt.2023.01.011

Jowsey-Gregoire S, Jannetto PJ, Jesse MT, Fleming J, Winder GS, Balliet W, Kuntz K, Vasquez A, Weinland S, Hussain F, Weinrieb R, Fireman M, Nickels MW, Peipert JD, Thomas C, Zimbrean PC Substance use screening in transplant populations: Recommendations from a consensus workgroup. , Transplantation Reviews. 36(2):100694, 2022 04., 36(2): 2022

Weinrieb RM, DiMartini AF The Role of Psychosocial Screening Tools in the Evaluation of Alcohol Associated Liver Transplant Patients , Liver Transplantation: 2022

Weinrieb Robert M, Lucey Michael R, Stanfield, Dylan The Use of Marijuana by Liver Transplant Candidates and Recipients: is the smoke starting to clear? , Digestive Medicine Research Website: http://dmr.amegroups.com/, 4: 2021

Trofe-Clark J, Malat G, Norris M, Bleicher M, Smith E, Sawinski D, Weinrieb R, Bloom R Comparison of Stanford Integrated Psychosocial Assessment for Transplantation Scores to Medication Adherence Assessment Findings in Kidney Transplant Candidates Undergoing Living Donor Transplant , American Transplant Congress: 2021

Deutsch‐Link S, Weinberg EM, Bitterman T, McDougal M, Dhariwal A, Jones LS, Weinrieb RM, Banerjee AG, Addis S, Serper M The Stanford Integrated Psychosocial Assessment for Transplant is Associated with Outcomes Before and After Liver Transplantation , Liver Transplantation, 27(5): 2021,652-667